Colotech A/S is a pharmaceutical development company

• The development of pharmaceutical products is based on established technologies
  
  
• The mechanisms of the active agents in the medicaments are well-established
  
  
• The core R&D area is cancer chemoprevention 
  
  
• The first chemopreventive drug for prevention of colorectal cancer is currently tested in an international, multicenter phase III trial
  
  
• Three chemopreventive drugs for prevention of lung, urinary bladder and skin cancer have been tested in animal models. A clinical trial in lung cancer prevention is being draftet. The use and indications are firmly protected by worldwide patents. A product patent is pending.